January was a busy month for Berkeley Lab startups. Second Genome announced its drug to treat inflammatory bowel disease had entered Phase 1 testing (read more here). Lithium ion battery startup Seeo reached a key testing phase in the development of its next generation technology (read more here). The CEO of WaterHealth International participated in the US-India Forum, … [Read more...] about Berkeley Lab Startups in the News
Groundbreaker Second Genome Featured in Fast Company
The evolution of biotech company Second Genome and its focus on finding a platform to cure disease are detailed in a feature piece by Fast Company. Second Genome was spun out from work by Berkeley Lab researchers Gary Andersen and Todd DeSantis. To read the entire piece, go here. … [Read more...] about Groundbreaker Second Genome Featured in Fast Company
Humanitarian Invention Licensed by Oakland-based Company
The Darfur cookstove, designed at Berkeley Lab and recently licensed to Oakland-based Potential Energy, was featured on KQED's Quest website. Potential Energy will produce and deliver the stoves to people in need in the Sudan. The Darfur stove works with traditional regional cookstoves to operate more efficiently, reducing the time and resources to obtain firewood. Limiting … [Read more...] about Humanitarian Invention Licensed by Oakland-based Company
Active Modulators and Perfect Shielders Based on Adiabatic Elimination 2014-090
For data and communications device companies that use waveguides to guide light in nanoscale circuits but are dissatisfied with noise and weak signal strength due to signal leakage, this new Berkeley Lab technology’s three-waveguide system is based on an adiabatic elimination (AE) mechanism that uses the middle “dark state” waveguide to separate the two outer waveguides and … [Read more...] about Active Modulators and Perfect Shielders Based on Adiabatic Elimination 2014-090
Centromere/Kinetochore Protein Genes for Cancer Prognosis, Diagnosis, and Treatment 2013-163
Based on a signature of 21 CEN/KT genes demonstrated to be linked to the progression of many different types of cancers, this technology has the potential to identify early stage patients at high risk for disease progression, predict survival prognosis and the risk of metastatic relapse for patients being treated for multiple cancers at various pathological stages, and predict … [Read more...] about Centromere/Kinetochore Protein Genes for Cancer Prognosis, Diagnosis, and Treatment 2013-163